Browse the latest stories and reports on MSF from various media outlets.

Country/Region

November 20, 2013

Johan von Schreeb, an MSF surgeon in Guiuan, the Philippines, speaks about the urgent need to treat injuries from the typhoon, which are at risk of serious and life-threatening infections.

View external media

November 19, 2013

MSF's Natasha Reyes describes the destruction and medical needs in Guiuan, where Typhoon Haiyan first made landfall in the Philippines.

View external media

November 18, 2013

An MSF team had 80 patients within an hour of their arrival in Santa Fe, a typhoon-damaged inland town on the Philippines' Leyte Island.

View external media

November 15, 2013

MSF's Damien Moloney describes efforts to set up an inflatable field hospital in Tacloban, the Philippines, in the aftermath of Typhoon Haiyan.

View external media

November 13, 2013

MSF's emergency teams in the Philippines are encountering immense needs and logistical difficulties in areas devastated by Typhoon Haiyan.

View external media 

November 11, 2013

MSF's emergency coordinator Natasha Reyes describes the destruction and injuries caused by Typhoon Haiyan in the Philippines.

View external media

June 28, 2013

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

April 02, 2013

  A landmark ruling by India's Supreme Court underscores the need for patients to have access to generic medications at affordable prices, according to MSF's Jennifer Cohn.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

February 09, 2012

Hundreds of people marched in New Delhi on Friday to protest an ambitious free-trade agreement being negotiated between India and the European Union that patient groups and health activists say could severely curtail India's production and export of affordable drugs for millions living with HIV in developing countries.

Pages